Medical management of pediatric intestinal failure

Seminars in Pediatric Surgery

Volumn 19, Issue 1, 2010, Pages 20-26

  Kocoshis, Samuel A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Intestinal adaptation; Intestinal failure; Parenteral nutrition associated cholestasis; Short bowel syndrome; Trophic hormones

Indexed keywords

CYANOCOBALAMIN; EPIDERMAL GROWTH FACTOR; GLUCAGON LIKE PEPTIDE 2; IRON; OMEGAVEN; ZINC;

ARTICLE; BACTERIAL OVERGROWTH; CENTRAL VENOUS CATHETER; CHOLESTASIS; COPPER DEFICIENCY; CYANOCOBALAMIN DEFICIENCY; DIETARY FIBER; ELECTROLYTE BALANCE; ENTERIC FEEDING; ENTEROPATHY; FLUID BALANCE; GASTROINTESTINAL DISEASE; HUMAN; INTESTINAL FAILURE; INTESTINE ABSORPTION; INTESTINE ADAPTATION; IRON DEFICIENCY; LACTIC ACIDOSIS; LIVER DISEASE; LONG TERM CARE; MALABSORPTION; NUTRIENT SUPPLY; PRIORITY JOURNAL; SHORT BOWEL SYNDROME; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME; ZINC DEFICIENCY;

ADAPTATION, PHYSIOLOGICAL; CHILD; GASTROINTESTINAL HORMONES; HUMANS; INFANT, NEWBORN; LIVER DISEASES; MALABSORPTION SYNDROMES; PARENTERAL NUTRITION, TOTAL; RECOVERY OF FUNCTION; SHORT BOWEL SYNDROME;

EID: 72549113418     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2009.11.003     Document Type: Article

References (39)

1. Kocoshis S.A., Goulet O., Kaufman S.S., et al. Report to the world congress of pediatric gastroenterology from the working group on intestinal failure and small bowel transplantation. J Pediatr Gastroenterol Nutr 39 (2004) S655-S661
2. Urban E., and Michel A.M. Separation of adaptive mucosal growth and transport after small bowel resection. Am J Physiol 244 (1983) G295-G300
3. Müller T., Hess M.W., Schiefermeier N., et al. MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity. Nat Genet 40 (2008) 1163-1165
4. Sivagnanam M., Mueller J.L., Lee H., et al. Identification of EpCAM as the gene for congenital tufting enteropathy. Gastroenterology 135 (2008) 429-437
5. Bousvaros A., Leichtner A.M., Book L., et al. Treatment of pediatric autoimmune enteropathy with tacrolimus (FK506). Gastroenterology 111 (1996) 237-243
6. Yong P.L., Russo P., and Sullivan K.E. Use of sirolimus in IPEX and IPEX-like children. J Clin Immunol 28 (2008) 581-587
7. Lee O.K., and Johnston L. A systematic review for effective management of central venous catheters and catheter sites in acute care pediatric patients. Worldviews Evid Based Nurs 2 (2005) 4-13
8. Onland W., Shin C.E., Fustar S., et al. Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. Arch Pediatr Adolesc Med 160 (2006) 1049-1053
9. Jones M.O., Pierro A., Hammond P., et al. Glucose utilization in the surgical newborn infant receiving total parenteral nutrition. J Pediatr Surg 28 (1993) 1121-1125
10. Schwartz K.B., Ternberg J.L., Bell M.J., et al. Sodium needs of infants and children with ileostomy. J Pediatr 102 (1983) 509-513
11. Santongo T.A., Azzam R., and Charrow J. Vitamin B12 status, methylmalonic acidemia, and bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr 48 (2009) 495-497
12. Maynor L., and Brophy D.F. Risk of infection with intravenous iron therapy. Ann Pharmacother 41 (2007) 1476-1480
13. Shulman R.J. Zinc and copper balance studies in infants receiving TPN. Am J Clin Nutr 49 (1989) 879-883
14. Hurwitz M., Garcia M.G., Poole R.L., et al. Copper deficiency during parenteral nutrition: a report of four pediatric cases. Nutr Clin Pract 19 (2004) 305-308
15. Erikson K.M., Thompson K., Ashner J., et al. Manganese neurotoxicity: a special focus on neonates. Pharmacol Ther 113 (2007) 369-377
16. Goulet O., Joly F., Corriol O., et al. Some new insights in intestinal failure-associated liver disease. Curr Opin Organ Transplant 14 (2009) 256-261
17. Shin J.I., Namgung R., Park M.S., et al. Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates?. Eur J Pediatr 167 (2008) 197-202
18. Jeejeebhoy K.N. Enteral nutrition versus parenteral nutrition-the risks and benefits. Nat Clin Pract Gastroenterol Hepatol 4 (2007) 260-265
19. Gura K.M., Lee S., Valim C., et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 121 (2008) e678-e686
20. Schlotzer E., and Kanning U. Elimination and tolerance of a new parenteral lipid emulsion: (SMOF)-a double-blind cross-over study in healthy male volunteers. Ann Nutr Metab 48 (2004) e263-e268
21. Hyman P.E., Everett S.L., and Harada T. Gastric acid hypersecretion in short bowel syndrome in infants: association with extent of resection and enteral feeding. J Pediatr Gastroenterol Nutr 5 (1987) 191-197
22. Kaufman S.S., Loseke C.A., Lupo J.V., et al. Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome. J Pediatr 131 (1997) 356-361
23. Perlmutter D.H., Boyle J.T., Campos J.M., et al. D-lactic acidosis in children: an unusual metabolic complication of small bowel resection. J Pediatr 102 (1983) 234-238
24. Donnell S.C., Taylor N., van Saene H.K., et al. Nutritional implications of gut overgrowth and selective decontamination of the digestive tract. Proc Nutr Soc 57 (1998) 381-387
25. Land M.H., Rouster-Stevens K., Woods C.R., et al. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115 (2005) 178-181
26. Parker P., Stroop S., and Greene H. A controlled comparison of continuous versus intermittent feeding in the treatment of infants with intestinal disease. J Pediatr 99 (1987) 360-364
27. Joly F., Dray X., Corcos O., et al. Tube feeding improves intestinal absorption in short bowel syndrome patients. Gastroenterology 136 (2009) 824-831
28. Andorsky D.J., Lund D.P., Lillehei C.W., et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr 139 (2001) 27-33
29. Bines J., Francis D., and Hill D. Reducing parenteral requirement in children with short bowel syndrome: impact of an amino acid-based complete infant formula. J Pediatr Gastroenterol Nutr 26 (1998) 123-128
30. Woolf G.M., Miller C., Kurian R., et al. Diet for patients with short bowel: high fat or high carbohydrate?. Gastroenterology 84 (1983) 823-828
31. Jeppesen P.B., and Mortensen P.B. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut 43 (1998) 478-483
32. Alkalay A.L., Fleisher D.R., Pomerance J.J., et al. Management of premature infants with extensive bowel resection with high volume enteral exudates. Isr J Med Sci 31 (1995) 298-302
33. Matarese L.E., O'Keefe S.J., Kandil H.M., et al. Short bowel syndrome: clinical guidelines for nutrition management. Nutr Clin Pract 20 (2005) 493-502
34. Musch M.W., Bookstein C., Xie Y., et al. SCFA increase intestinal Na absorption by induction of NHE3 in rat colon and human intestinal C2/bbe cells. Am J Physiol Gastrointest Liver Physiol 280 (2001) G687-G693
35. Pereira P.M., and Bines J. New growth factor therapies aimed at improving intestinal adaptation in short bowel syndrome. J Gastroenterol Hepatol 21 (2006) 932-940
36. Byrne T.A., Persinger R.L., Young L.S., et al. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg 222 (1995) 243-254
37. Scolapio J.S. Effect of growth hormone, glutamine, and diet on body composition in short bowel syndrome: a randomized, controlled study. J Parenter Enteral Nutr 23 (1999) 309-312
38. Jeppesen P.B., Sanguinetti E.L., Buchman A., et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 54 (2005) 1224-1231
39. O'Keefe S., Gilroy R., Jeppesen P.B., et al. 212 Teduglutide, a novel GLP-2 analog, in the management of short bowel syndrome (SBS) patients dependent on parenteral nutrition: a multicenter, multinational placebo-controlled clinical trial. Gastroenterology 134 (2008) A37